These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24451478)

  • 1. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.
    Klarer AC; O'Neal J; Imbert-Fernandez Y; Clem A; Ellis SR; Clark J; Clem B; Chesney J; Telang S
    Cancer Metab; 2014 Jan; 2(1):2. PubMed ID: 24451478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
    Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
    J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
    Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
    Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
    Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
    FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.
    Tian W; Guo HS; Li CY; Cao W; Wang XY; Mo D; Hao XW; Feng YD; Sun Y; Lei F; Zhang HN; Zhao MG; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 368():26-36. PubMed ID: 30776389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3PO inhibits inflammatory NFκB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3.
    Wik JA; Lundbäck P; la Cour Poulsen L; Haraldsen G; Skålhegg BS; Hol J
    PLoS One; 2020; 15(3):e0229395. PubMed ID: 32130250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
    Imbert-Fernandez Y; Clem BF; O'Neal J; Kerr DA; Spaulding R; Lanceta L; Clem AL; Telang S; Chesney J
    J Biol Chem; 2014 Mar; 289(13):9440-8. PubMed ID: 24515104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.
    Clem BF; O'Neal J; Tapolsky G; Clem AL; Imbert-Fernandez Y; Kerr DA; Klarer AC; Redman R; Miller DM; Trent JO; Telang S; Chesney J
    Mol Cancer Ther; 2013 Aug; 12(8):1461-70. PubMed ID: 23674815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
    Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
    FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells.
    Kotowski K; Supplitt S; Wiczew D; Przystupski D; Bartosik W; Saczko J; Rossowska J; Drąg-Zalesińska M; Michel O; Kulbacka J
    Anticancer Res; 2020 May; 40(5):2613-2625. PubMed ID: 32366406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
    Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
    J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFKFB3 Inhibitor 3PO Reduces Cardiac Remodeling after Myocardial Infarction by Regulating the TGF-β1/SMAD2/3 Pathway.
    Yang Q; Zong X; Zhuang L; Pan R; Tudi X; Fan Q; Tao R
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro angiogenesis inhibition with selective compounds targeting the key glycolytic enzyme PFKFB3.
    Abdali A; Baci D; Damiani I; Belloni F; De Dominicis C; Gelmi ML; Corsini A; Bellosta S
    Pharmacol Res; 2021 Jun; 168():105592. PubMed ID: 33813027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of targeting PFKFB3 as a therapeutic strategy against cancer.
    Lu L; Chen Y; Zhu Y
    Oncotarget; 2017 Sep; 8(37):62793-62802. PubMed ID: 28977989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets.
    Kotowski K; Rosik J; Machaj F; Supplitt S; Wiczew D; Jabłońska K; Wiechec E; Ghavami S; Dzięgiel P
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
    Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M
    Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27.
    Yalcin A; Clem BF; Imbert-Fernandez Y; Ozcan SC; Peker S; O'Neal J; Klarer AC; Clem AL; Telang S; Chesney J
    Cell Death Dis; 2014 Jul; 5(7):e1337. PubMed ID: 25032860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
    Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
    Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.
    Yan S; Zhou N; Zhang D; Zhang K; Zheng W; Bao Y; Yang W
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.